|
|
|
|
|
|
| Senior Vice President, Global Operations Management, honored for contributions to clinical innovation and process improvement |
Raleigh, N.C., Aug 2, 2013 - (ACN Newswire) - INC Research LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced Jeff Kueffer, Senior Vice President, Global Operations Management, has been named to the annual PharmaVOICE 100 list of the most inspiring people in the life-sciences industry. Mr. Kueffer was selected for his ability to shape the next-generation clinical development methodologies and tools needed for drug developers to effectively compete in an evolving landscape, which includes driving the development and evolution of the Company's proprietary Trusted Process(R).
"Jeff has contributed to INC Research's success by boldly challenging convention in clinical development, keeping our Company at the leading edge of the industry," said Jamie Macdonald, Chief Executive Officer. "He was ahead of his time in measuring the impact of processes on trial quality and delivery, and our proven Trusted Process(R) methodology continues to benefit our customers and the industry as a whole."
Mr. Kueffer has been driving clinical development improvements since joining INC Research nearly a decade ago. His distinguished history of leadership in the U.S. military contributes to his disciplined approach to problem solving-a hallmark of his success at the Company. He continues to be a driving force behind INC Research's Trusted Process(R), the proprietary metrics-driven clinical trial outsourcing methodology, which has underpinned every trial conducted by INC since 2006. Through development and implementation of this standardized process, Mr. Kueffer has made it possible to reduce variability in clinical trials and increase both efficiency and speed. He remains dedicated to improving INC Research's efficiency in performing clinical trials and is currently playing a key role in the Company's initiative focused on delivering clinical innovation to enhance the drug development process.
Featured in the July/August 2013 issue of PharmaVOICE, Mr. Kueffer was selected from a group of nominations submitted by industry peers. A panel of PharmaVOICE editors evaluated the submissions based on nominees' ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing, and strategy. Mr. Kueffer's profile is featured in the "Change Agents" section of the special issue, a section dedicated to innovators who are improving clinical development.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. Our Trusted Process(R) methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact:
Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Awards
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
